To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Automated External Defibrillator Market size was valued at USD 17 billion in 2022 and is poised to grow from USD 18.8 billion in 2023 to USD 39.1 billion by 2031, at a CAGR of 11% in the forecast period (2024-2031).

Intense competition among major competitors vying for market supremacy characterises the competitive environment of the automated external defibrillator market. firms with broad product portfolios and business alliances, such Philips Healthcare, ZOLL Medical Corporation, and Stryker Corporation, control large market shares. In this crucial medical device industry, up-and-coming companies like Physio-Control and Cardiac Science Corporation are also making noteworthy progress, encouraging innovation and boosting competitiveness. 'Nihon Kohden Corporation (Japan)', 'Asahi Kasei Medical Co., Ltd (Japan)', 'Cardiac Science Corporation (The U.S)', 'Zoll Medical Corporation (The U.S)', 'Koninklijke Philips N.V. (Netherlands)', 'Biotronik (Germany). GE Healthcare (The U.S)', 'Schiller AG (Switzerland)', 'Stryker Corporation (The U.S)', 'Mindray Medical International Limited (China)', 'Physio-Control Corporation (The U.S)', 'Metrax GmbH (Germany)', 'Boston Scientific Corporation', 'CU Medical Systems Inc.', 'Philips Healthcare', 'HeartSine Technologies (part of Stryker Corporation)', 'Welch Allyn (now part of Hillrom)'

With an electric shock to the heart, the automated external defibrillator can help restore abnormal cardiac rhythms, which is why it is becoming more and more popular. In the upcoming years, it is anticipated that the worldwide market for automated external defibrillators will offer revenue-generating potential due to the rising use of this device in the treatment of patients experiencing sudden cardiac arrest. Additionally, a rise in the number of smokers and alcohol addicts could open profitable business prospects.

Uprising in Automated External Defibrillators: Technology is advancing quickly in the industry. Artificial intelligence (AI), cloud connectivity, and smart features are just a few examples of how AEDs are being improved in terms of usability, accuracy, and connectivity to improve patient outcomes and enable remote monitoring.

The US and Canada make up the two largest segments of the North American market for automated external defibrillators. The largest market for automated external defibrillators is the United States. The market is primarily driven by a large population with diabetes, a significant growth in respiratory disorders, and a growing public awareness of respiratory diseases. For automated external defibrillators, the United States is expected to be the largest market because of several factors, including a rise in the prevalence of cardiovascular disease (CVDs). The market for automated external defibrillators is growing at the fastest rate in Asia Pacific as factors such increased rates of cardiovascular disease, developing healthcare systems, and government programmes that encourage public access to these life-saving equipment. Elevated adoption rates in the region can also be attributed to increased awareness and training initiatives.

Feedback From Our Clients

Global Automated External Defibrillators Market

Product ID: SQMIG35A2871